The Motley Fool

These 2 Cannabis Stocks Just Dropped in Price, but Are They a Buy?

It was a great week for cannabis stocks. Or at least, it would have been, but for Friday.

For some reason, investors took the opportunity to take their gains and go on a lot of cannabis stocks. Canopy Growth Corp.Aurora Cannabis Inc., and Hexo Corp. were just some of the stocks seeing losses that brought them back to Monday’s share prices.

Two other cannabis stocks that saw a loss were Cronos Group Inc. (TSX:CRON)(NYSE:CRON) and Aphria Inc. (TSX:APHA)(NYSE:APHA). These names have remained among many of the heavy hitters since legalization, but before you go ahead and buy more of the above stocks mentioned at these lower prices, let’s look at whether it’d be such a great idea.


It’s not hard to find overvalued cannabis stocks, but when it comes to Cronos, it’s pretty much a miracle that its share price has remained so high. This could be due to the recent closure of the deal between Cronos and Altria Group. The cigarette giant invested $1.8 billion in the cannabis company, in return getting a 45% stake in Cronos. This has given Cronos international reach overnight.

But international reach doesn’t mean much if you don’t have the product, and right now, Cronos only has the capacity to produce 120,000 kilograms. Hopefully it uses the Altria cash to expand, but it’s all “coulds” and “shoulds” until there are any real announcements.

So while the deal is great for Cronos, and will be for investors in the far-off future, right now it’s a waiting game. The stock is trading at about $26 per share at writing, but analysts are putting its fair value closer to $18. Ouch. So if it were me, I’d wait until the share price reaches that range before buying.


Another stock fuelled by recent news is Aphria Inc. This cannabis company recently received a full production license from Health Canada to expand its Aphria One production facility. The news means that Aphria can seriously ramp up production in the 800,000 square-foot facility to produce 115,000 kilograms per year.

While that’s good news, it hasn’t helped the recent drama surrounding Aphria. The company was accused by short sellers of purchasing shell companies in Latin America that proved to be “largely worthless,” selling those companies almost immediately at insane prices to pocket the cash.

Of course the company denies these claims, and a report has since been released stating that Aphria paid a reasonable amount for the Latin American cannabis companies. But it definitely shook the stock for months.

Now the company is seeing a rebound, but analysts are still placing the current share price at pretty near fair value. In this case, it’s a gamble to purchase it right now. While the news of a production license means Aphria could be back in the spot of lowest cost per gram of cannabis producer, it still needs to prove its worth to investors.

Bottom line

Both Cronos and Aphria have a ways to go to show investors that these companies deserve their money. At the end of this wild ride of a week, I’d be more interested in a few steadier options before heading down a potentially turbulent path like Cronos or Aphria.

The 10 Best Stocks to Buy This Month

Renowned Canadian investor Iain Butler just named 10 stocks for Canadians to buy TODAY. So if you’re tired of reading about other people getting rich in the stock market, this might be a good day for you. Because Motley Fool Canada is offering a full 65% off the list price of their top stock-picking service, plus a complete membership fee back guarantee on what you pay for the service. Simply click here to discover how you can take advantage of this.

Click Here to Learn More Today!

Fool contributor Amy Legate-Wolfe has no position in any of the stocks mentioned.

I consent to receiving information from The Motley Fool via email, direct mail, and occasional special offer phone calls. I understand I can unsubscribe from these updates at any time. Please read the Privacy Statement and Terms of Service for more information.